PAVmed Inc

Company Profile

PAVmed Inc had its IPO on 2016-04-28 under the ticker symbol PAVM.

The company operates in the Healthcare sector and Medical Devices industry. PAVmed Inc has a staff strength of 124 employees.

Stock update

Shares of PAVmed Inc opened at $0.52 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.38 - $0.53, and closed at $0.39.

This is a -20.9% slip from the previous day's closing price.

A total volume of 3,136,126 shares were traded at the close of the day’s session.

In the last one week, shares of PAVmed Inc have increased by +4.13%.

PAVmed Inc's Key Ratios

PAVmed Inc has a market cap of $54.71 million, indicating a price to book ratio of 8.3288 and a price to sales ratio of 86.5234.

In the last 12-months PAVmed Inc’s revenue was $800000 with a gross profit of $-3237000 and an EBITDA of $-81792000. The EBITDA ratio measures PAVmed Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, PAVmed Inc’s operating margin was -10586.5% while its return on assets stood at -77.76% with a return of equity of -466.36%.

In Q2, PAVmed Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 136%.

PAVmed Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.9 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PAVmed Inc’s profitability.

PAVmed Inc stock is trading at a EV to sales ratio of 65.5494 and a EV to EBITDA ratio of -0.3882. Its price to sales ratio in the trailing 12-months stood at 86.5234.

PAVmed Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$53.68 million

Total Liabilities

$50.79 million

Operating Cash Flow

$-15000.00

Capital Expenditure

$15000

Dividend Payout Ratio

0%

PAVmed Inc ended 2024 with $53.68 million in total assets and $0 in total liabilities. Its intangible assets were valued at $53.68 million while shareholder equity stood at $-31512000.00.

PAVmed Inc ended 2024 with $0 in deferred long-term liabilities, $50.79 million in other current liabilities, 109000.00 in common stock, $-260783000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $37.16 million and cash and short-term investments were $37.16 million. The company’s total short-term debt was $44,417,000 while long-term debt stood at $0.

PAVmed Inc’s total current assets stands at $43.13 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $41000.00 compared to accounts payable of $1.16 million and inventory worth $243000.00.

In 2024, PAVmed Inc's operating cash flow was $-15000.00 while its capital expenditure stood at $15000.

Comparatively, PAVmed Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.39

52-Week High

$1.25

52-Week Low

$0.21

Analyst Target Price

$2.98

PAVmed Inc stock is currently trading at $0.39 per share. It touched a 52-week high of $1.25 and a 52-week low of $1.25. Analysts tracking the stock have a 12-month average target price of $2.98.

Its 50-day moving average was $0.35 and 200-day moving average was $0.45 The short ratio stood at 10.14 indicating a short percent outstanding of 0%.

Around 911.8% of the company’s stock are held by insiders while 972.2% are held by institutions.